Research-Grade Anastrozole Overview
Anastrozole is a non-steroidal aromatase inhibitor that serves as a critical research tool for investigating estrogen biosynthesis pathways. The ARIMIROW formulation from cRowX Labs enables researchers to examine the competitive inhibition of aromatase enzyme (CYP19A1) activity in laboratory settings. As an established pharmaceutical reference compound, anastrozole provides researchers with reliable methodology for studying estrogen reduction mechanisms across various experimental models. Investigators at Stroid UK Shop utilize anastrozole to explore hormonal modulation pathways and their downstream effects on cellular metabolism.
Laboratory Research Applications
Research teams investigate anastrozole’s mechanism of action through its selective binding to the aromatase enzyme active site, effectively blocking the conversion of androgens to estrogens in experimental systems. Studies examining aromatase inhibitor compounds frequently employ anastrozole as a reference standard due to its well-characterized pharmacological profile. Laboratory investigations focus on its reversible competitive inhibition properties, enabling researchers to evaluate dose-response relationships in controlled environments. Scientists studying endocrine disruption models utilize anastrozole to establish baseline conditions for comparative analysis. Research applications extend to examining tissue-specific aromatase expression patterns and their modulation under various experimental conditions. Investigators exploring metabolic pathways often incorporate anastrozole studies alongside selective androgen receptor modulators and peptide research compounds to understand complex hormonal interactions.
Technical Specifications
| Chemical Name | 2,2′-(5-((1H-1,2,4-triazol-1-yl)methyl)-1,3-phenylene)dipropanenitrile |
|---|---|
| CAS Number | 120511-73-1 |
| Molecular Formula | C₁₇H₁₉N₅ |
| Molecular Weight | 293.37 g/mol |
| Storage Conditions | Room temperature, dry environment, protect from light |
| Solubility | DMSO, ethanol, limited aqueous solubility |
Research Compliance Statement
This anastrozole compound is manufactured exclusively for in-vitro laboratory research purposes. ARIMIROW is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must comply with institutional safety protocols and regulatory guidelines when handling this material. All studies should be conducted by qualified personnel in appropriate laboratory facilities with proper safety equipment and disposal procedures.

